Histone-specific CD4+ T-cell plasticity in active and quiescent systemic lupus erythematosus.


Journal

Arthritis & rheumatology (Hoboken, N.J.)
ISSN: 2326-5205
Titre abrégé: Arthritis Rheumatol
Pays: United States
ID NLM: 101623795

Informations de publication

Date de publication:
18 Dec 2023
Historique:
revised: 31 10 2023
received: 23 03 2023
accepted: 27 11 2023
medline: 19 12 2023
pubmed: 19 12 2023
entrez: 19 12 2023
Statut: aheadofprint

Résumé

To assess whether circulating histone-specific T-cells represent tools for precision medicine in systemic lupus erythematosus (SLE) METHODS: Seroprevalence of autoantibodies and human leukocyte antigen (HLA)-DRB1 profile were assessed among 185 patients with SLE and combined with bioinformatics and literature evidence to identify HLA-peptide autoepitope couples for ex vivo detection of antigen-specific T-cells through flow cytometry. T-cell differentiation and polarisation was investigated in subjects with SLE, Takayasu's arteritis and healthy controls (HC) carrying HLA-DRB1*03:01 and/or 11:01. SLE disease activity index 2000 (SLEDAI-2K) and Lupus low disease activity state (LLDAS) were used to estimate disease activity and remission. Histone-specific CD4+ T-cells were selectively detected in patients with SLE. Among patients with a history of anti-DNA antibodies, 77% had detectable histone-specific T-cells while 50% had lymphocytes releasing cytokines or upregulating activation markers after in vitro challenge with histone peptide antigens. Histone-specific regulatory and effector Th1-, Th2-, Th1*-polarised cells were significantly more abundant in SLE patients with quiescent disease. In contrast, total Th1-, Th2-, Th1*-polarised and regulatory T-cells were similarly represented between patients and controls or SLE patients with active vs quiescent disease. Histone-specific effector memory T-cells accumulated in the blood of patients with quiescent SLE, while total effector memory T-cell counts did not change. Immunosuppressants were associated with expanded CD4+ histone-specific naïve and terminally differentiated T-cells. Histone-specific T-cells are selectively detected in patients with SLE and their concentration in the blood varies with disease activity, suggesting that they represent innovative tools for patient stratification and therapy.

Identifiants

pubmed: 38111123
doi: 10.1002/art.42778
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

This article is protected by copyright. All rights reserved.

Auteurs

Giuseppe A Ramirez (GA)

Università Vita-Salute San Raffaele, Milan, Italy.
Division of Immunology, Transplantation & Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.
Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.

Elena Tassi (E)

Unit of Experimental Haematology, IRCCS Ospedale San Raffaele, Milan, Italy.
MITiCi: "Cell Therapy Immunomonitoring Laboratory (MITiCi), Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.

Maddalena Noviello (M)

Unit of Experimental Haematology, IRCCS Ospedale San Raffaele, Milan, Italy.
MITiCi: "Cell Therapy Immunomonitoring Laboratory (MITiCi), Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.

Benedetta A Mazzi (BA)

Immunogenetics Laboratory, HLA & Chimerism, Department of Immunohematology & Blood Transfusion, IRCCS Ospedale San Raffaele, Milan, Italy.

Luca Moroni (L)

Università Vita-Salute San Raffaele, Milan, Italy.
Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.

Lorena Citterio (L)

Unit of Genomics of Renal Diseases and Hypertension, IRCCS Ospedale San Raffaele, Milan, Italy.

Laura Zagato (L)

Unit of Genomics of Renal Diseases and Hypertension, IRCCS Ospedale San Raffaele, Milan, Italy.

Enrico Tombetti (E)

Università Vita-Salute San Raffaele, Milan, Italy.
Division of Immunology, Transplantation & Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.
Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.

Matteo Doglio (M)

Unit of Experimental Haematology, IRCCS Ospedale San Raffaele, Milan, Italy.

Elena M Baldissera (EM)

Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.

Enrica P Bozzolo (EP)

Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.

Chiara Bonini (C)

Università Vita-Salute San Raffaele, Milan, Italy.
Unit of Experimental Haematology, IRCCS Ospedale San Raffaele, Milan, Italy.
MITiCi: "Cell Therapy Immunomonitoring Laboratory (MITiCi), Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.

Lorenzo Dagna (L)

Università Vita-Salute San Raffaele, Milan, Italy.
Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.

Angelo A Manfredi (AA)

Università Vita-Salute San Raffaele, Milan, Italy.
Division of Immunology, Transplantation & Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.
Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.

Classifications MeSH